Discovery Reorg

Big changes and RIF coming in September! CV future?

 

What is RIF and what have you heard about CV?

 

RIF = reduction in force = layoff

 

and CV is a fat load.....

 

CV R&D is a bust, only 4 drugs in P1 and P2 clinical trials and 0 in P3.

 

Big reorg going on quitely.. People are being booted out in small numbers and no word on it. Discovery small molecule chemistry is going to be hit hard.

 

Confirmed, chemistry is on the chopping block... much of the Carter Rd crew won't be returning.

 

Bristol likes to layoff 10 here and 20 there to stay just under the WARN threshold. It keeps them out of the headlines.

 

Good luck folks ! These are rough times..
Keep updating if you all hear anything !

 

Percy has his list completed

 

Great, Giovanni and Francis are gorging themselves on discovery budget in order to feed their lack of discipline in Ph3 trial design. Just like being in small biotech -- cut discovery in order to pay for clinical trials as soon as you have something hot - except there's no chance of getting pre-IPO shares or becoming a millionaire.

 

Another figment of your imagination, Giovanni and Francis unconditionally and selflessly putting patients first. Nothing to see here, move along.

 

CV gone!

 

Like "80% reduce in staff" gone, or all CV discovery gone?

How can they say to wall st that they have any diversity if they're only in IO and IMM? There's huge risk in IO right now: bad reimbursement, a gazillion other mABS coming on the market to lower prices...CV shows Wall St that BMS knows how to balance risks across a portfolio.

Does Giovanni have any vision? The last bad ph3 result made the stock drop 20%. If BMS turns into just IO and IMM, then after the AZ and Roche mAbs get into the market, prices will drop and overall revenue will be slaughtered. They need CV and something unless the idea is to be bought by Pfizer. These guys don't think big enough to run a big pharma, they are small time biotech.

 

CV to become licensing operation... major cost cuts needed to fund Opdivo losses and support trials.

 

Bristol needs to step on the gas or be left in the dust by Merck and Roche

 

Any news in PCO ? I heard Hopewell site is affected !

 

They have no vision whatsoever. CV has great assets and the best validated one in the whole R&D and they will let it go to cash in fast. They're a bunch of beginners who will tear BMS apart.

 

Massive layoffs coming... reset for the future.